Here are a few notable developments that will continue to advance our understanding of COVID-19 throughout 2021 and beyond.
Several new FDA-approved tests based upon mass spectrometry showcase the power of mass spec, not only as a discovery technology, but as a platform for critical public health challenges.
The QX ONE System streamlines the droplet digital PCR workflow by combining droplet generation, thermal cycling, and droplet reading into a single, fully automated process.
Researchers have begun to dissect SARS-CoV-2 effects on the blood brain barrier, making use of innovative cell culture models, techniques, and equipment
Several new platforms have recently launched for foodborne pathogen analysis, those which may offer promising solutions to the growing body of food safety challenges.
The successful application of NGS technologies to a problem of this scale and scope speaks to the power of innovation. Here are a few new NGS solutions for COVID-19 research applications.
By automating tasks and increasing precision, new liquid handling technologies serve to streamline workflows and free up the hands of researchers to focus on the important stuff – the science.
New products and technologies are helping to arm scientists and medical professionals – providing the insight needed in the fight against this unprecedented viral disease.
Understanding the strengths and limitations of real-time RT-PCR is essential for examining the current virus outbreak and for those that may emerge in the future.
Bold innovations in sample collection, point of care detection, immunity profiling and other applications are adding new firepower in the fight against COVID-19.
Companies have stepped forward with innovative products in the areas of personal protective equipment, testing and diagnostics, safety and automation, and others in the fight against the COVID-19 pandemic.
The Emerging Trends in Infectious Disease Interactive Infographic is a living resource -- this post serves as a chronology of the infographic, citing ongoing developments in the areas of: Detection and Containment, Diagnosis and Treatment, Laboratory Equipment, and Prevention and Surveillance.
Challenges with the approval of COVID-19 test diagnostics uncovered serious process issues that are now being resolved in order to contain the current outbreak and to fight future pathogens.
The iQ-Check Real-Time PCR Kit from Bio-Rad for Rapid Detection of Pathogenic Aspergillus in Cannabis
The iQ-Check Aspergillus kit offers rapid detection of the four pathogenic Aspergillus species of concern, A. flavus, A. fumigatus, A. niger, and A. terreus, with high sensitivity and specificity in a range of cannabis sample backgrounds.